Anatomy and physiology of the luminal gut: Enteral access implications

Journal of Parenteral and Enteral Nutrition

Volumn 30, Issue SUPPL. 1, 2006, Pages

  Grant, John P ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANATOMY; CONFERENCE PAPER; ENTERIC FEEDING; ESOPHAGUS; FEEDING APPARATUS; GASTROSTOMY; HUMAN; LONG TERM CARE; MOUTH; NOSE FEEDING; PRIORITY JOURNAL; STOMACH; VASCULAR ACCESS;

ENTERAL NUTRITION; GASTROINTESTINAL TRACT; HUMANS; INTUBATION, GASTROINTESTINAL;

EID: 30744469590     PISSN: 01486071     EISSN: None     Source Type: Journal    
DOI: 10.1177/01486071060300S1S41     Document Type: Conference Paper

References (4)

1. Li SJ, Nussbaum MS, McFadden DW, et al. Addition of L-glutamine to total parenteral nutrition and its effects on portal insulin and glucagon and the development of hepatic steatosis in rats. J Surg Res. 1990;48:421-426. Level 3 Evidence
2. Burke DJ, Alverdy JC, Aoys E, Moss GS. Glutamine-supplemented total parenteral nutrition improves gut immune function. Arch Surg. 1989;124:1396-1399. Level 3 Evidence
3. Lin HC, van Gitters GW. Stopping enteral feeding for arbitrary gastric residual volume may not be physiologically sound: results of a computer simulation model. JPEN J Patenter Enteral Nutr. 1997;21:286-289. Level 5 Evidence: A well designed computer simulation model calculated the cumulative gastric residual volume over time when the input volume into the stomach was 125 mL/h (endogenous secretions)+ 0-125 mL/h (formula delivery rate) and the output volume out of the stomach is equal to gastric emptying rates that varied between 0% and 50% /h.
4. Wilmore DW, Lacey JM, Soultanakis RP, Bosch RL, Byrne TA. Factors predicting a successful outcome after pharmacologic bowel compensation. Ann Surg. 1997;226:288-293. Level 3 Evidence: Longitudinal study using the patient as their own control. Forty-five PN-dependent adults with a jejunal-ileal remnant ≤50 cm and a portion of colon in continuity were treated with growth hormone, glutamine, and a modified diet for 4 weeks and observed for an average of 1.8 years. The ability to wean off PN was associated with greater bowel length, lower body weight, and greater bowel length-body weight ratio.